| Medical and Health Sciences | Lifetime | 116 | SG 3 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 420 | SG 4 | 99.91 |
| Surgery | Lifetime | 76 | SG 1 | 99.93 |
| Epidemiology | Lifetime | 106 | SG 2 | 99.84 |
| Gastroenterology | Lifetime | 19 | SG 1 | 99.79 |
| Oncology | Lifetime | 148 | SG 1 | 99.76 |
| Pulmonary and Respiratory Medicine | Lifetime | 239 | SG 1 | 99.71 |
| Infectious Diseases | Lifetime | 261 | SG 3 | 99.06 |
| Health Informatics | Lifetime | 19 | SG 1 | 97.03 |
| Hepatology | Lifetime | 181 | SG 2 | 98.66 |
| Clinical Pharmacology | Lifetime | 527 | SG 4 | 97.74 |
| Cancer Research | Lifetime | 505 | SG 2 | 96.85 |
| Pathology and Forensic Medicine | Lifetime | 679 | SG 2 | 96.92 |
| Health Informatics | 2021-2025 | 11 | SG 1 | 98.98 |
| Oncology | 2021-2025 | 276 | SG 2 | 97.55 |
| Molecular Biology | 2021-2025 | 797 | SG 2 | 95.61 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 341 | SG 12 | 93.29 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 3 | SG 1 | 99.96 |
| Gastrointestinal disorders and treatments | Lifetime | 3 | SG 1 | 99.95 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 1 | SG 1 | 99.98 |
| Gastric Cancer Management and Outcomes | Lifetime | 10 | SG 2 | 99.95 |
| COVID-19 Clinical Research Studies | Lifetime | 17 | SG 1 | 99.87 |
| Colorectal Cancer Screening and Detection | Lifetime | 8 | SG 1 | 99.91 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 41 | SG 2 | 99.76 |
| Genetic factors in colorectal cancer | Lifetime | 33 | SG 1 | 99.79 |
| Liver Disease Diagnosis and Treatment | Lifetime | 96 | SG 1 | 99.82 |
| Hepatitis B Virus Studies | Lifetime | 55 | SG 1 | 99.77 |
| Inflammatory mediators and NSAID effects | Lifetime | 37 | SG 1 | 99.52 |
| Eosinophilic Esophagitis | Lifetime | 40 | SG 2 | 99.68 |
| Esophageal and GI Pathology | Lifetime | 70 | SG 2 | 99.63 |
| Cancer-related molecular mechanisms research | Lifetime | 132 | SG 2 | 99.34 |
| Gallbladder and Bile Duct Disorders | Lifetime | 65 | SG 1 | 99.58 |
| Gastroesophageal reflux and treatments | Lifetime | 47 | SG 2 | 99.52 |
| Hepatitis C virus research | Lifetime | 112 | SG 2 | 99.61 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 68 | SG 1 | 99.43 |
| Cancer-related gene regulation | Lifetime | 98 | SG 2 | 99.27 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 28 | SG 2 | 98.49 |
| Biliary and Gastrointestinal Fistulas | Lifetime | 40 | SG 1 | 99.16 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 115 | SG 1 | 99.17 |
| Gut microbiota and health | Lifetime | 305 | SG 2 | 98.92 |
| Epigenetics and DNA Methylation | Lifetime | 522 | SG 4 | 98.72 |
| MicroRNA in disease regulation | Lifetime | 552 | SG 2 | 98.23 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 558 | SG 3 | 98.69 |
| COVID-19 diagnosis using AI | Lifetime | 96 | SG 1 | 97.57 |
| Inflammatory Bowel Disease | Lifetime | 253 | SG 1 | 98.76 |
| Liver Disease and Transplantation | Lifetime | 431 | SG 1 | 98.85 |
| Gastrointestinal motility and disorders | Lifetime | 215 | SG 1 | 98.26 |
| Cancer, Lipids, and Metabolism | Lifetime | 457 | SG 1 | 98.25 |
| Veterinary medicine and infectious diseases | Lifetime | 101 | SG 2 | 97.72 |
| Viral gastroenteritis research and epidemiology | Lifetime | 701 | SG 5 | 98.12 |
| Microscopic Colitis | Lifetime | 321 | SG 1 | 98.34 |
| Circular RNAs in diseases | Lifetime | 421 | SG 3 | 97.38 |
| Mycobacterium research and diagnosis | Lifetime | 543 | SG 3 | 97.43 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 166 | SG 2 | 96.18 |
| Diverticular Disease and Complications | Lifetime | 303 | SG 4 | 97.41 |
| Abdominal vascular conditions and treatments | Lifetime | 317 | SG 2 | 94.28 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 974 | SG 3 | 96.06 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 783 | SG 3 | 94.96 |
| Infection Control and Ventilation | Lifetime | 327 | SG 6 | 94.12 |
| Autoimmune and Inflammatory Disorders | Lifetime | 399 | SG 1 | 94.43 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 704 | SG 5 | 94.21 |
| Complementary and Alternative Medicine Studies | Lifetime | 597 | SG 3 | 92.84 |
| Machine Learning in Healthcare | Lifetime | 921 | SG 16 | 83.65 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 425 | SG 4 | 68.99 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 19 | SG 1 | 99.40 |
| Gut microbiota and health | 2021-2025 | 128 | SG 2 | 98.74 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 38 | SG 2 | 98.48 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 546 | SG 2 | 96.37 |
| Gastrointestinal Bleeding Diagnosis and Treatment | 2021-2025 | 54 | SG 1 | 94.04 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 848 | SG 4 | 94.18 |
| Genetic factors in colorectal cancer | 2021-2025 | 442 | SG 2 | 92.33 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 769 | SG 1 | 85.82 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 575 | SG 2 | 84.51 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 206 | SG 3 | 79.91 |
| Gastrointestinal disorders and treatments | 2021-2025 | 928 | SG 4 | 80.53 |
| Micro and Nano Robotics | 2021-2025 | 624 | SG 5 | 82.33 |
| Machine Learning in Healthcare | 2021-2025 | 951 | SG 20 | 74.19 |
| Ethics in Clinical Research | 2021-2025 | 843 | SG 6 | 73.80 |
